Work

PS02.08 Evidence of Clinical Activity of Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitor Therapy

Year: 2017

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.046

Authors: T.A. Leal, L. Horn, K. Velastegui, J. Christensen, I. Chen, A. Spira

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Mirati Therapeutics (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2765160392

Cites:

Cited by: 4

Related to: 10